Effects of a controlled-release formulation of methylphenidate on vital signs in school-aged youths with attention-deficit/hyperactivity disorder

被引：0

作者：

Biederman, J ^{[1
]}

Wilens, TE ^{[1
]}

机构：

[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA

来源：

EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2002年 / 12卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：S414 / S414

页数：1

相关论文

共 2 条

[1]

Wilens Timothy E., 2001, Pediatric Research, V49, p429A

[2] Randomized, controlled trial of OROS methylphenidate once a day in children with attention-deficit/hyperactivity disorder [J].

Wolraich, ML ;

Greenhill, LL ;

Pelham, W ;

Swanson, J ;

Wilens, T ;

Palumbo, D ;

Atkins, M ;

McBurnett, K ;

Bukstein, O ;

August, G .

PEDIATRICS, 2001, 108 (04) :883-892